Nolin, Thomas D.
University of Pittsburgh,
United States
2025 Rank: 153689
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 973 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 153689 | 155007 |
| Total Cites | 461 | 508 |
| H-index | 9 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 41 | 41 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 122 | 132 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 398 | 430 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
9.25%
|
|
Nolin, Thomas D.
University of Pittsburgh,
United States
2024 Rank: 130979
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 877 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130979 | 146055 |
| Total Cites | 467 | 542 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 46 | 50 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 138 | 148 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 400 | 435 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.25 |
| Self-Citation Percentage |
13.84%
|
|
Nolin, Thomas D.
University of Pittsburgh,
United States
2023 Rank: 159734
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1147 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159734 | 142398 |
| Total Cites | 453 | 536 |
| H-index | 10 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 7 | 9 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 41 | 50 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 130 | 145 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 393 | 424 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.26 |
| Self-Citation Percentage |
15.49%
|
|
Nolin, Thomas D.
University of Pittsburgh,
United States
2022 Rank: 137745
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1016 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137745 | 133857 |
| Total Cites | 407 | 486 |
| H-index | 10 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 7 | 8 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 54 | 58 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 137 | 147 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 357 | 385 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.26 |
| Self-Citation Percentage |
16.26%
|
|
Nolin, Thomas D.
University of Pittsburgh,
United States
2021 Rank: 113657
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 855 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113657 | 101886 |
| Total Cites | 640 | 767 |
| H-index | 13 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 12 | 15 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 86 | 94 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 213 | 231 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 522 | 574 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.34 |
| Self-Citation Percentage |
16.56%
|
|
Nolin, Thomas D.
University of Pittsburgh,
United States
2020 Rank: 96404
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 754 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96404 | 96961 |
| Total Cites | 523 | 588 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 12 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 75 | 82 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 171 | 186 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 407 | 442 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
11.05%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.